These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31978564)

  • 1. Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis.
    Wang BC; Fu C; Qin L; Zeng XY; Liu Q
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101667. PubMed ID: 31978564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for basal cell carcinoma of the skin.
    Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
    Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
    Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of photodynamic therapy with amino-5-laevulinate nanoemulsion versus methyl-5-aminolaevulinate for actinic keratosis: A meta-analysis.
    Fu C; Kuang BH; Qin L; Zeng XY; Wang BC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():408-414. PubMed ID: 31310826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
    Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
    Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy using methyl aminolevulinate in the management of primary superficial basal cell carcinoma: clinical and health economic outcomes.
    Caekelbergh K; Nikkels AF; Leroy B; Verhaeghe E; Lamotte M; Vincent R
    J Drugs Dermatol; 2009 Nov; 8(11):992-6. PubMed ID: 19894366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
    Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
    J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
    Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
    Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
    Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
    Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
    Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
    Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
    Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for cutaneous Bowen's disease.
    Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical methyl aminolevulinate.
    Siddiqui MA; Perry CM; Scott LJ
    Am J Clin Dermatol; 2004; 5(2):127-37; discussion 138-40. PubMed ID: 15109276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.
    Horn M; Wolf P; Wulf HC; Warloe T; Fritsch C; Rhodes LE; Kaufmann R; De Rie M; Legat FJ; Stender IM; Solér AM; Wennberg AM; Wong GA; Larkö O
    Br J Dermatol; 2003 Dec; 149(6):1242-9. PubMed ID: 14674903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
    Collier NJ; Haylett AK; Wong TH; Morton CA; Ibbotson SH; McKenna KE; Mallipeddi R; Moseley H; Seukeran D; Ward KA; Mohd Mustapa MF; Exton LS; Green AC; Rhodes LE
    Br J Dermatol; 2018 Dec; 179(6):1277-1296. PubMed ID: 29889302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexyl aminolevulinate, 5-aminolevulinic acid nanoemulsion and methyl aminolevulinate in photodynamic therapy of non-aggressive basal cell carcinomas: A non-sponsored, randomized, prospective and double-blinded trial.
    Salmivuori M; Grönroos M; Tani T; Pölönen I; Räsänen J; Annala L; Snellman E; Neittaanmäki N
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2781-2788. PubMed ID: 32196772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl aminolevulinate photodynamic therapy after partial debulking in the treatment of superficial and nodular basal cell carcinoma: 3-years follow-up.
    Gómez C; Cobos P; Alberdi E
    Photodiagnosis Photodyn Ther; 2021 Mar; 33():102176. PubMed ID: 33429099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
    Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
    Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers.
    Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.
    Gracia-Cazaña T; Mascaraque M; Lucena SR; Vera-Álvarez J; González S; Juarranz Á; Gilaberte Y
    PLoS One; 2019; 14(4):e0215537. PubMed ID: 31017970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.